Energy Boost

The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.

After six weeks of talks, Pfizer and Pharmacia Corp. executives told the J. Walter Thompson crew pitching the new est arthritis drug that there was good news and bad news. The bad news: The $70-80 million account was going to Deutsch. The good news: Client executives had decided to shift the $100 million Celebrex account from Leo Burnett to JWT.

“The team was very, very impressed,” says Pharmacia’s Sharon Fairley, executive director of consumer marketing, praising JWT’s enthusiasm and command of the category.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in